Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

701–725 of 17978

HighFDA (Drugs)·D-0137-2026·2025-11-05
Testosterone and triamcinolone 200 mg pellets recalled over metal particulate matter
FarmaKeio Outsourcing is recalling 264,664 sterile Testosterone / Triamcinolone Acetonide 200MG/40MCG pellets over the potential presence of metal particulate matter.
Product
Testosterone / Triamcinolone Acetonide Pellet (200MG/40MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0364-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0107-2026·2025-11-05
Desipramine tablets recalled over nitrosamine impurity above acceptable daily intake
Heritage Pharmaceuticals is recalling 6,979 bottles of Desipramine Hydrochloride Tablets USP 10 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Product
DESIPRAMINE HYDROCHLORIDE — DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0105-2026·2025-11-05
Prazosin capsules recalled over nitrosamine impurity above the acceptable intake limit
Teva Pharmaceuticals USA is recalling 291,512 bottles of Prazosin Hydrochloride Capsules 2 mg because test results for N-nitroso Prazosin impurity C exceeded the acceptable intake limit.
Product
PRAZOSIN HYDROCHLORIDE — PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0113-2026·2025-11-05
Compounded pain injection syringes recalled over presence of particulate matter
QuVa Pharma is recalling 75,885 syringes of its R.E.C.K. periarticular injection over the presence of particulate matter.
Product
R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land,
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0135-2026·2025-11-05
Testosterone and triamcinolone 87.5 mg pellets recalled over metal particulate matter
FarmaKeio Outsourcing is recalling 21,324 sterile Testosterone / Triamcinolone Acetonide 87.5MG/17.5MCG pellets over the potential presence of metal particulate matter.
Product
Testosterone / Triamcinolone Acetonide 87.5MG/17.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0382-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0129-2026·2025-11-05
Testosterone 200 mg pellets recalled over potential metal particulate matter
FarmaKeio Outsourcing is recalling 14,329 sterile Testosterone Regular Release 200 mg pellets over the potential presence of metal particulate matter.
Product
Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0402-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0104-2026·2025-11-05
Prazosin 1 mg capsules recalled over nitrosamine impurity above intake limit
Teva Pharmaceuticals USA is recalling 181,659 bottles of Prazosin Hydrochloride Capsules 1 mg because test results for N-nitroso Prazosin impurity C exceeded the acceptable intake limit.
Product
PRAZOSIN HYDROCHLORIDE — PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0140-2026·2025-11-05
Everolimus 7.5 mg tablets recalled after an out of specification impurity result
Endo USA is recalling 1,866 cartons of Everolimus tablets 7.5 mg after results came back out of specification for impurity IP-C.
Product
Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-127-91
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0142-2026·2025-11-05
Everolimus 2.5 mg tablets recalled after an out of specification impurity result
Endo USA is recalling 2,035 cartons of Everolimus tablets 2.5 mg after results came back out of specification for impurity IP-C.
Product
Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0145-2026·2025-11-05
Lisdexamfetamine 20 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 20 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0144-2026·2025-11-05
Lisdexamfetamine 10 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 10 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0150-2026·2025-11-05
Lisdexamfetamine 70 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 70 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0138-2026·2025-11-05
Lipophilic foam base recalled over an unclassified labeling problem
Letco Medical is recalling 173 500 ml bottles of Espumil lipophilic foam base over a labeling issue recorded as not elsewhere classified.
Product
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Category
Drug
Distribution
1 state
ModerateFDA (Drugs)·D-0141-2026·2025-11-05
Everolimus 10 mg tablets recalled after an out of specification impurity result
Endo USA is recalling 935 cartons of Everolimus tablets 10 mg after results came back out of specification for impurity IP-C.
Product
Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0149-2026·2025-11-05
Lisdexamfetamine 60 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 60 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0148-2026·2025-11-05
Lisdexamfetamine 50 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 50 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0139-2026·2025-11-05
Everolimus tablets recalled after an out of specification impurity result
Endo USA is recalling 6,655 cartons of Everolimus tablets 5 mg after results came back out of specification for impurity IP-C.
Product
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0146-2026·2025-11-05
Lisdexamfetamine 30 mg capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 30 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0122-2026·2025-11-05
Sting relief swabs recalled from one lot over a product mix-up
Acme United Corporation is recalling 2,338 boxes of First Aid Only Sting Relief Swabs from one lot over a product mix-up.
Product
Sting Relief Swabs, First Aid Only, 10 Swabs per box, part number 19-001, Manufactured for: Acme United Corporation, 1 Waterview Dr. Shelton, CT, Made in the USA UPC 738743190015
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0147-2026·2025-11-05
Lisdexamfetamine capsules recalled after failing dissolution at twelve month stability
Sun Pharmaceutical Industries is recalling two lots of Lisdexamfetamine Dimesylate Capsules 40 mg after an out-of-specification dissolution result at the 12-month stability station.
Product
LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0121-2026·2025-11-05
Extra Strength Tylenol caplets recalled from one lot for defective container
Kenvue Brands is recalling 3,816 bottles of Extra Strength TYLENOL 500mg caplets, 24-count, from one lot because of a defective container.
Product
TYLENOL EXTRA STRENGTH — TYLENOL EXTRA STRENGTH (ACETAMINOPHEN)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0097-2026·2025-10-29
Opdualag injection vials recalled from one lot over sterility assurance
Bristol-Myers Squibb is recalling 12,778 vials of Opdualag (nivolumab and relatlimab-rmbw) injection from one lot for lack of assurance of sterility.
Product
OPDUALAG — OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0035-2026·2025-10-29
Alcohol prep pads recalled from one lot as a subpotent drug
Medline is recalling 222,800 alcohol prep pads from one lot because the product is subpotent.
Product
Medline, Alcohol Prep Pads (2-Ply Pad, 70% Isopropyl Alcohol), 100 eaches per box, 10 boxes per case (1,000 eaches per case), Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL, 60093 USA, NDC 55329-811-30.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0036-2026·2025-10-29
Ketorolac injection vials recalled after glass particulate found in product
Aspiro Pharma is recalling Ketorolac Tromethamine Injection USP 60 mg/2 mL across several lots because of particulate matter identified as glass.
Product
KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0034-2026·2025-10-29
Olopatadine eye drops recalled after unspecified impurity exceeded specification limit
USV Private Limited is recalling 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% after an unspecified impurity exceeded the specification limit.
Product
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

701–725 of 17978